Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 3.33
MR's Cash to Debt is ranked higher than
77% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. MR: 3.33 )
MR' s 10-Year Cash to Debt Range
Min: 0.65   Max: No Debt
Current: 3.33

Equity to Asset 0.67
MR's Equity to Asset is ranked higher than
76% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. MR: 0.67 )
MR' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.89
Current: 0.67

0.32
0.89
Interest Coverage 33.13
MR's Interest Coverage is ranked higher than
74% of the 208 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.54 vs. MR: 33.13 )
MR' s 10-Year Interest Coverage Range
Min: 17.97   Max: 9999.99
Current: 33.13

17.97
9999.99
F-Score: 4
Z-Score: 4.86
M-Score: -2.53
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 15.84
MR's Operating margin (%) is ranked higher than
87% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. MR: 15.84 )
MR' s 10-Year Operating margin (%) Range
Min: 17.32   Max: 27.61
Current: 15.84

17.32
27.61
Net-margin (%) 15.87
MR's Net-margin (%) is ranked higher than
91% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.09 vs. MR: 15.87 )
MR' s 10-Year Net-margin (%) Range
Min: 17   Max: 26.52
Current: 15.87

17
26.52
ROE (%) 13.72
MR's ROE (%) is ranked higher than
86% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.62 vs. MR: 13.72 )
MR' s 10-Year ROE (%) Range
Min: 14.57   Max: 128.45
Current: 13.72

14.57
128.45
ROA (%) 8.87
MR's ROA (%) is ranked higher than
86% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. MR: 8.87 )
MR' s 10-Year ROA (%) Range
Min: 10.31   Max: 85.21
Current: 8.87

10.31
85.21
ROC (Joel Greenblatt) (%) 52.10
MR's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.33 vs. MR: 52.10 )
MR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 49.57   Max: 227.92
Current: 52.1

49.57
227.92
Revenue Growth (%) 19.10
MR's Revenue Growth (%) is ranked higher than
93% of the 279 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. MR: 19.10 )
MR' s 10-Year Revenue Growth (%) Range
Min: 15.5   Max: 55.3
Current: 19.1

15.5
55.3
EBITDA Growth (%) 13.80
MR's EBITDA Growth (%) is ranked higher than
83% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. MR: 13.80 )
MR' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 62.4
Current: 13.8

0
62.4
EPS Growth (%) 12.30
MR's EPS Growth (%) is ranked higher than
80% of the 241 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. MR: 12.30 )
MR' s 10-Year EPS Growth (%) Range
Min: 0   Max: 63
Current: 12.3

0
63
» MR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MR Guru Trades in Q3 2013

Jim Simons 358,000 sh (+38.33%)
Manning & Napier Advisors, Inc 5,631,533 sh (+23.71%)
John Hussman 22,500 sh (unchged)
Robert Karr 2,014,532 sh (-10.38%)
Matthews China Fund 970,568 sh (-12.18%)
» More
Q4 2013

MR Guru Trades in Q4 2013

Frank Sands 6,155 sh (New)
John Rogers 33,088 sh (New)
Matthews China Fund 998,168 sh (+2.84%)
John Hussman 22,500 sh (unchged)
Jim Simons Sold Out
Manning & Napier Advisors, Inc 4,627,432 sh (-17.83%)
Robert Karr 656,715 sh (-67.4%)
» More
Q1 2014

MR Guru Trades in Q1 2014

Jim Simons 212,150 sh (New)
Frank Sands 433,390 sh (+6941.27%)
John Rogers 56,448 sh (+70.6%)
John Hussman 22,500 sh (unchged)
Matthews China Fund 998,168 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Robert Karr Sold Out
» More
Q2 2014

MR Guru Trades in Q2 2014

Jim Simons 400,500 sh (+88.78%)
John Rogers 76,981 sh (+36.38%)
Frank Sands 463,790 sh (+7.01%)
Matthews China Fund 998,168 sh (unchged)
John Hussman Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Hussman 2014-06-30 Sold Out 0.06%$30.1 - $34.4 $ 30.04-5%0
Frank Sands 2014-03-31 Add 6941.27%0.04%$30.41 - $40.2 $ 30.04-14%433390
Frank Sands 2013-12-31 New Buy$35.61 - $42.07 $ 30.04-23%6155
John Hussman 2012-06-30 Add 350%0.01%$28.6 - $33.61 $ 30.04-5%22500
Daniel Loeb 2011-12-31 Sold Out 0.31%$23.71 - $28.06 $ 30.0417%0
John Hussman 2011-12-31 Add 150%$23.71 - $28.06 $ 30.0417%5000
Daniel Loeb 2011-09-30 New Buy0.31%$21.36 - $28.29 $ 30.0418%275000
George Soros 2011-09-30 Sold Out 0.1085%$21.36 - $28.29 $ 30.0418%0
George Soros 2011-06-30 New Buy0.11%$25.4 - $30.47 $ 30.049%275000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.90
MR's P/E(ttm) is ranked higher than
92% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.90 vs. MR: 17.90 )
MR' s 10-Year P/E(ttm) Range
Min: 16.7   Max: 95.74
Current: 17.9

16.7
95.74
P/B 2.40
MR's P/B is ranked higher than
77% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. MR: 2.40 )
MR' s 10-Year P/B Range
Min: 2.32   Max: 13.78
Current: 2.4

2.32
13.78
P/S 2.80
MR's P/S is ranked higher than
73% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. MR: 2.80 )
MR' s 10-Year P/S Range
Min: 2.73   Max: 25.03
Current: 2.8

2.73
25.03
PFCF 20.70
MR's PFCF is ranked higher than
92% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 123.13 vs. MR: 20.70 )
MR' s 10-Year PFCF Range
Min: 15.03   Max: 73.33
Current: 20.7

15.03
73.33
EV-to-EBIT 14.78
MR's EV-to-EBIT is ranked higher than
87% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.54 vs. MR: 14.78 )
MR' s 10-Year EV-to-EBIT Range
Min: 14.3   Max: 92.4
Current: 14.78

14.3
92.4
PEG 1.73
MR's PEG is ranked higher than
94% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 1.73 )
MR' s 10-Year PEG Range
Min: 0.39   Max: 2.67
Current: 1.73

0.39
2.67
Shiller P/E 19.80
MR's Shiller P/E is ranked higher than
94% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 19.80 )
MR' s 10-Year Shiller P/E Range
Min: 19.15   Max: 42.2
Current: 19.8

19.15
42.2
Current Ratio 3.30
MR's Current Ratio is ranked higher than
80% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.81 vs. MR: 3.30 )
MR' s 10-Year Current Ratio Range
Min: 1.52   Max: 6.71
Current: 3.3

1.52
6.71
Quick Ratio 2.91
MR's Quick Ratio is ranked higher than
83% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. MR: 2.91 )
MR' s 10-Year Quick Ratio Range
Min: 1.28   Max: 6.24
Current: 2.91

1.28
6.24

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.70
MR's Dividend Yield is ranked higher than
59% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. MR: 1.70 )
MR' s 10-Year Dividend Yield Range
Min: 0.41   Max: 2.02
Current: 1.7

0.41
2.02
Dividend Payout 0.30
MR's Dividend Payout is ranked higher than
87% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 0.30 )
MR' s 10-Year Dividend Payout Range
Min: 0.52   Max: 1.67
Current: 0.3

0.52
1.67
Dividend growth (3y) 42.20
MR's Dividend growth (3y) is ranked higher than
99% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. MR: 42.20 )
MR' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 42.2
Current: 42.2

0
42.2
Yield on cost (5-Year) 7.34
MR's Yield on cost (5-Year) is ranked higher than
94% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. MR: 7.34 )
MR' s 10-Year Yield on cost (5-Year) Range
Min: 1.77   Max: 8.73
Current: 7.34

1.77
8.73
Share Buyback Rate -0.70
MR's Share Buyback Rate is ranked higher than
81% of the 240 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.60 vs. MR: -0.70 )
MR' s 10-Year Share Buyback Rate Range
Min: 0   Max: -11
Current: -0.7

Valuation & Return

vs
industry
vs
history
Price/Net Cash 20.58
MR's Price/Net Cash is ranked higher than
89% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 20.58 )
MR' s 10-Year Price/Net Cash Range
Min: 10.34   Max: 556.33
Current: 20.58

10.34
556.33
Price/Net Current Asset Value 8.83
MR's Price/Net Current Asset Value is ranked higher than
88% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 8.83 )
MR' s 10-Year Price/Net Current Asset Value Range
Min: 6.12   Max: 186.13
Current: 8.83

6.12
186.13
Price/Tangible Book 3.57
MR's Price/Tangible Book is ranked higher than
78% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.41 vs. MR: 3.57 )
MR' s 10-Year Price/Tangible Book Range
Min: 3.29   Max: 17.44
Current: 3.57

3.29
17.44
Price/DCF (Projected) 1.16
MR's Price/DCF (Projected) is ranked higher than
92% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. MR: 1.16 )
MR' s 10-Year Price/DCF (Projected) Range
Min: 1.23   Max: 6.63
Current: 1.16

1.23
6.63
Price/Median PS Value 0.64
MR's Price/Median PS Value is ranked higher than
94% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. MR: 0.64 )
MR' s 10-Year Price/Median PS Value Range
Min: 0.68   Max: 4.06
Current: 0.64

0.68
4.06
Price/Peter Lynch Fair Value 2.01
MR's Price/Peter Lynch Fair Value is ranked higher than
92% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MR: 2.01 )
MR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 2.49
Current: 2.01

0.7
2.49
Price/Graham Number 1.65
MR's Price/Graham Number is ranked higher than
90% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.99 vs. MR: 1.65 )
MR' s 10-Year Price/Graham Number Range
Min: 1.57   Max: 6.62
Current: 1.65

1.57
6.62
Earnings Yield (Greenblatt) 6.80
MR's Earnings Yield (Greenblatt) is ranked higher than
81% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. MR: 6.80 )
MR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 7
Current: 6.8

1.1
7
Forward Rate of Return (Yacktman) 10.14
MR's Forward Rate of Return (Yacktman) is ranked higher than
83% of the 266 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.14 vs. MR: 10.14 )
MR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.7   Max: 44.4
Current: 10.14

-0.7
44.4

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:G2N.Germany
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices. Its business is segmented into three - patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems.
» More Articles for NYSE:MR

Headlines

Articles On GuruFocus.com
Matthews China Fund's Top Second Quarter Holdings Jul 31 2014 
Guru Held International Stocks Near 52-Week Lows Jul 31 2014 
Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 16 2014 
The Matthews China Fund's Top Five Fourth Quarter Holdings Feb 04 2014 
12 Healthcare Dividend Stocks With Highest Short Float Ratio Jun 02 2012 
value May 05 2012 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
growth,high ROA,medi Oct 29 2011 
100 Best Growth Stocks – Part VII May 12 2011 

More From Our Partners
3 Stocks Dragging In The Electronics Industry Sep 29 2014 - THESTREET

More From Other Websites
The Zacks Analyst Blog Highlights: Yingli Green Energy Holding, JD.com, Mindray Medical... Sep 24 2014
Top Foreign Stock Funds Sep 17 2014
Quality Exams at Your Fingertips Sep 17 2014
Mindray Medical Down to Strong Sell on Weak Q2 Sep 09 2014
Asia Morning Read: Solar Module Shortage, Chinese Hackers Aug 18 2014
The Zacks Analyst Blog Highlights: ReneSola, eLong, China Unicom Hong Kong, Mindray Medical... Aug 15 2014
Mindray Medical Beats Q2 Earnings by a Penny, Cuts 2014 View Aug 12 2014
Mindray Medical International Ltd Earnings Call scheduled for 8:00 am ET today Aug 12 2014
Mindray Announces Second Quarter 2014 Financial Results Aug 11 2014
Stocks squeeze out gains; geopolitics, data eyed Aug 11 2014
Q2 2014 Mindray Medical International Limited Earnings Release - After Market Close Aug 11 2014
Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street... Aug 01 2014
Mindray to Report Second Quarter 2014 Financial Results on August 11, 2014 Jul 15 2014
Sluggish Chinese Market Continues to Drag Down Mindray Medical Jun 27 2014
Survey Shows Strong Potential In Healthcare May 30 2014
Mindray Medical International Honors Altera with Best Quality Award for Delivering Industry-leading... May 28 2014
Mindray Medical Misses on Q1 Earnings May 07 2014
Mindray Medical International Limited (MR) Crumbles: Stock Falls by 6.1% May 07 2014
China’s Mindray Medical Leads Retreat as Sales Disappoint May 06 2014
Mindray Medical International (MR) Q1 2014 Results - Earnings Call Transcript May 06 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK